We are monitoring the impact of COVID-19 on APAC Immunoassay Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 1492
Share on
Share on

Asia-Pacific Immunoassay Market Research Report – Segmented By Technology, Application, End Users, Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) - Industry Analysis, Size, Share, Growth, Trends and Forecast (2021 to 2026)

Pulished: April, 2021
ID: 1492
Pages: 132

APAC Immunoassay Market Size (2020 to 2025)

The size of the Immunoassay Market in the Asia Pacific was worth USD 3.97 Billion in 2020 and is estimated to reach 6.42 Billion by the end of 2025, with a CAGR of 10.12%.  

The Asia-pacific market is expected to show the highest growth over the forecast period due to the increasing development of new biologics, drugs, and vaccines.

Immunoassays are biochemical tests used to identify/quantify an analyte in a blood sample using a reaction. Immunoassays are highly specific and sensitive. Their high specificity/sensitivity results from the use of antibodies and purified analytes as reagents. An antibody is a protein produced by immune cells in response to stimulation by an analyte. Immunoassays measure the formation of antibody-antigen complexes and identify them through an indicator reaction. High sensitivity is attained by using an indicator system that results in the intensification of the measured product.

The key drivers of the Asia-Pacific immunoassays market are the rising prevalence of infectious diseases, increasing aging population, advancements in novel assays in various diseases such as Cardiology and oncology, growing applications in diagnosing drug monitoring tests, infectious diseases and identification of cancer biomarkers, increasing need of reagents, sensitive assays and analytical techniques, availability of a wide range of reagents, the introduction of novel biomarkers, growing government and corporate investment in the pharmaceutical and biotechnology segment in emerging markets.

Lack of reimbursement policies, adoption of immunoassays in emerging markets, stringent regulations for storage are hampering the growth of the market.

This research report on the Asia-Pacific Immunoassay Market has been segmented & sub-segmented the market into the following categories:

By Technology:

  • Enzyme Immunoassays
  • Fluorescent Immunoassays
  • Chemiluminescence Immunoassays
  • Nephelometric Immunoassays
  • Radio Immunoassays
  • Counting Immunoassays
  • Turbidimetric Immunoassays

By Application:

  • Oncology
  • Cancer
  • Hematology
  • Cardiology
  • Thyroid
  • Infectious diseases
  • Allergies

By End User:

  • Hospitals
  • Clinics
  • Academic Research Institute
  • Pharmaceutical
  • Biotech vendors
  • Laboratories

By Country:

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

Key market participants dominating the Asia-Pacific immunoassay market analyzed in this report are Roche Diagnostics, DiaSorin S.p.A, Beckman Coulter, Siemens Healthcare, Ortho Clinical Diagnostics, bioMerieux, Thermo Fisher Scientific and Abbott Laboratories, Akers Biosciences, Inc, Becton Dickinson and Company, Devon Medical Products, EDP Biotech Corporation, Hologic (Gen-Probe), Intrinsic LifeSciences.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                             

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 Technology                

                                5.1.1 Introduction           

                                5.1.2 Enzyme Immunoassay       

                                5.1.3 Fluorescent Immunoassays             

                                5.1.4 Cheniluminescence Immunoassays              

                                5.1.5 Nephelometric Immunoassays       

                                5.1.6 Radio Immunoassays         

                                5.1.7 Counting Immunoassays  

                                5.1.8 Counting Immunoassays  

                                5.1.9 Others      

                                5.1.10 Y-o-Y Growth Analysis, By Technology      

                                5.1.11 Market Attractiveness Analysis, By Technology     

                                5.1.12 Market Share Analysis, By Technology      

                5.2 Application                 

                                5.2.1 Introduction           

                                5.2.2 Oncology 

                                5.2.3 Cancer      

                                5.2.4 Hematology           

                                5.2.5 Cardiology               

                                5.2.6 Thyroid     

                                5.2.7 Infectious disease

                                5.2.8 Allergies   

                                5.2.9 Others      

                                5.2.10 Y-o-Y Growth Analysis, By Application       

                                5.2.11 Market Attractiveness Analysis, By Application     

                                5.2.12 Market Share Analysis, By Application      

                5.3 End users                    

                                5.3.1 Introduction           

                                5.3.2 Hospitals  

                                5.3.3 Clinics        

                                5.3.4 Academic research institutes          

                                5.3.5 Pharmaceutical and Biotech vendors           

                                5.3.6 Laboratories           

                                5.3.7 Others      

                                5.3.8 Y-o-Y Growth Analysis, By End users            

                                5.3.9 Market Attractiveness Analysis, By End users           

                                5.3.10 Market Share Analysis, By End users          

6. Geographical Analysis                                              

                6.1 Introduction                              

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Technology

                                                6.1.3.3 By Application

                                                6.1.3.4 By End users

                                6.1.4 Market Attractiveness Analysis      

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Technology

                                                6.1.4.3 By Application

                                                6.1.4.4 By End users

                                6.1.5 Market Share Analysis        

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Technology

                                                6.1.5.3 By Application

                                                6.1.5.4 By End users

                6.2 China                            

                6.3 India                              

                6.4 Japan                            

                6.5 South Korea               

                6.6 Australia                      

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 Roche Diagnostics                    

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 DiaSorin S.p.A                           

                8.3 Beckman Coulter                     

                8.4 Siemens Healthcare                

                8.5 Ortho Clinical Diagnostics                     

                8.6 bioMerieux                

                8.7 Thermo Fisher Scientific                        

                8.8 Abbott Laboratories               

                8.9 Akers Biosciences                    

                8.10 Becton Dickinson and Company                      

                8.11 Devon Medical Products                    

                8.12 EDP Biotech Corporation                    

                8.13 Hologic                       

                8.14 Intrinsic LifeSciences                           

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Market Outlook and Investment Opportunities                                           

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia-Pacific Immunoassays Market, By Technology, From 2020 to 2025 (USD Billion)
  2. Asia-Pacific Enzyme Immunoassay Market, By Region, From 2020 to 2025 (USD Billion)
  3. Asia-Pacific Fluorescent Immunoassays Market, By Region, From 2020 to 2025 (USD Billion)
  4. Asia-Pacific Chemiluminescence Immunoassays Market, By Region, From 2020 to 2025 (USD Billion)
  5. Asia-Pacific Nephelometric Immunoassays Market, By Region, From 2020 to 2025 (USD Billion)
  6. Asia-Pacific Radio Immunoassays Market, By Region, From 2020 to 2025 (USD Billion)
  7. Asia-Pacific Counting Immunoassays Market, By Region, From 2020 to 2025 (USD Billion)
  8. Asia-Pacific Turbidimetric Immunoassays Market, By Region, From 2020 to 2025 (USD Billion)
  9. Asia-Pacific Immunoassays Market, By Application, From 2020 to 2025 (USD Billion)
  10. Asia-Pacific Oncology Market, By Region, From 2020 to 2025 (USD Billion)
  11. Asia-Pacific Cancer Market, By Region, From 2020 to 2025 (USD Billion)
  12. Asia-Pacific Hematology Market, By Region, From 2020 to 2025 (USD Billion)
  13. Asia-Pacific Cardiology Market, By Region, From 2020 to 2025 (USD Billion)
  14. Asia-Pacific Thyroid Market, By Region, From 2020 to 2025 (USD Billion)
  15. Asia-Pacific Infectious diseases Market, By Region, From 2020 to 2025 (USD Billion)
  16. Asia-Pacific Allergies Market, By Region, From 2020 to 2025 (USD Billion)
  17. Asia-Pacific Immunoassays Market, By End users, From 2020 to 2025 (USD Billion)
  18. Asia-Pacific Hospitals Market, By Region, From 2020 to 2025 (USD Billion)
  19. Asia-Pacific Clinics Market, By Region, From 2020 to 2025 (USD Billion)
  20. Asia-Pacific Academic research institutes Market, By Region, From 2020 to 2025 (USD Billion)
  21. Asia-Pacific Pharmaceutical and biotech vendors Market, By Region, From 2020 to 2025 (USD Billion)
  22. Asia-Pacific laboratories Market, By Region, From 2020 to 2025 (USD Billion)
  23. Japan Immunoassays Market, By Technology, From 2020 to 2025 (USD Billion)
  24. Japan Immunoassays Market, By Application, From 2020 to 2025 (USD Billion)
  25. Japan Immunoassays Market, By End users, From 2020 to 2025 (USD Billion)
  26. China Immunoassays Market, By Technology, From 2020 to 2025 (USD Billion)
  27. China Immunoassays Market, By Application, From 2020 to 2025 (USD Billion)
  28. China Immunoassays Market, By End users, From 2020 to 2025 (USD Billion)
  29. India Immunoassays Market, By Technology, From 2020 to 2025 (USD Billion)
  30. India Immunoassays Market, By Application, From 2020 to 2025 (USD Billion)
  31. India Immunoassays Market, By End users, From 2020 to 2025 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample